Phase 1/Phase 2
18 Years
65 Years
18 Years
65 Years
Open (Enrolling)
Both
Brain Tumors With Ill-defined Margins
Both
Brain Tumors With Ill-defined Margins
Trial Information
Inclusion Criteria:
- Subjects with gliomas or other tumors that may have ill defined margins during the
operative resection.
Exclusion Criteria:
- Subjects with a contraindication for brain MRI scan. Subjects who are pregnant,
younger than 18 years old or have a contraindication for indigo carmine are excluded
as well
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Extent of Resection
Outcome Description:
Evaluation of the extent of resection of the tumor following the indigo carmine infusion to the tumor.
Outcome Time Frame:
48 hours
Safety Issue:
No
Authority:
United States: Food and Drug Administration
Study ID:
1106011772
NCT ID:
NCT01767415
Start Date:
March 2012
Completion Date:
Related Keywords:
- Brain Tumors With Ill-defined Margins
- Brain Neoplasms
Name | Location |
|---|---|
| Weill Cornell Medical College Department of Neurological Surgery | New York, New York 10710 |
